Wednesday, January 21, 2015

Actavis - Barchart's Chart of the Day

Actavis (ACT) is the Barchart Chart of the Day.  The generic drug preparation company has a Trend Spotter buy signal, a Weighted Alpha of 55.40+ and gained 48.51% in the last year.

The Chart of the Day belongs to Actavis (ACT).  I found the stock by sorting the All Time High list for the stocks having the most frequent new highs in the last month then used the Flipchart feature to review the charts.  Since the Trend Spotter signaled another buy on 1/7 the stock gained 4.05%.

Actavis plc is a specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Its business is focused principally in the Urology and Women's Health therapeutic categories, as well as Gastroenterology and Dermatology.


Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.

Barchart technical indicators:

  • 100% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 7 new highs and up 4.00% in the last month
  • Relative Strength Index 63.70%
  • Barchart computes a technical support level at 264.04
  • Recently traded at 276.00 with a 50 day moving average of 261.07
Fundamental factors:
  • Market Cap $72.91 billion
  • P/E 20.25
  • Revenue expected to grow 46.00% this year and another 22.80% next year
  • Earnings estimated to increase 43.60% this year, an additional 21.60% next year and continue  to compound at an annual rate of 22.81% for the next 5 years
  • Wall Street analysts issued 10 strong buy, 10 buy and 2 hold recommendations on the stock
The most dependable technical trading strategy on this stock as been the 20 - 100 Day MACD Oscillator and should be used to trade this stock

No comments:

Post a Comment